Skip to content

Emergent Biosolutions EBS Book value per share

Book value per share at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$139.23+6.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$291.77+10.4%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$0.14+66.0%
CorMedix logo
CorMedixCRMD
$4.70+182%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$7.80+9.2%
Opko Health logo
Opko HealthOPK
$1.59-18.7%

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

Based on the most recent quarter.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's book value per share?
Emergent Biosolutions (EBS) reported book value per share of $9.26 in Q1 2026.
How has Emergent Biosolutions's book value per share changed year-over-year?
Emergent Biosolutions's book value per share decreased by 4.0% year-over-year, from $9.65 to $9.26.
What is the long-term trend for Emergent Biosolutions's book value per share?
Over 5 years (2020 to 2025), Emergent Biosolutions's book value per share has grown at a -19.3% compound annual growth rate (CAGR), from $26.97 to $9.22.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.